Moderate lifetime marijuana smoking not associated with lung function decline
the ONA take:
According to a new study published online in the journal Annals of the American Thoracic Society, researchers at Emory University in Atlanta, Georgia, have found that moderate lifetime marijuana use is associated with airway inflammation, but not significant changes in lung function.
For the study, researchers analyzed data from the National Health and Nutrition Examination Survey (NHANES). They identified over 5,000 adult survey participants with data on recent marijuana use and respiratory symptoms. Results showed that nearly 60% reported using marijuana at least once during their lifetime, and about 12% said they had used marijuana in the last month.
Among the 3,000 adult participants who had patterns of lifetime marijuana use, cumulative exposure of less than 20 joint-years was not linked with significant changes in lung function; however, more than 20 joint-years of marijuana exposure was associated with clinically significant changes in lung function.
The results do not show whether this change in lung function represents early lung function decline like that of long-term tobacco use. Researchers also found that marijuana smoking increased respiratory irritation, but the study could not determine whether those symptoms were permanent.
The researchers note that they did not assess an association between marijuana use and cancer.
Moderate lifetime marijuana use is associated with airway inflammation, but not significant changes in lung function.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- PPIs Negatively Impact Outcomes of Patients Treated With Capecitabine
- How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- Pseudohyperkalemia: False Potassium Levels Occur in a Patient With Lymphoma
- Atezolizumab Granted FDA Approval for Specific Cases of NSCLC
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- High U.S. Economic Burden for Vaccine-Preventable Diseases
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|